After completing post-doctoral training at the University of California at Irvine, Alan started as a Process Chemist with AstraZeneca in 2006. Alan joined CatSci Ltd in early 2020 to take up a pivotal role as Senior Principal Scientist. Alan applies his interests in enhanced chemical development, drug substance route invention and process design to projects across CatSci’s project portfolio. In collaboration with the ACS GCI Pharmaceutical Roundtable, Alan regularly contributes reviews of green chemistry and engineering to the wider community. Alan is responsible for the framework of scientific standards, and assists the technical team on scientific and technological aspects related to projects and business plans.
